Skip to main content

Find Clinical Trials

Home
Conditions
CLDN18.2 Positive

Clinical trial condition

CLDN18.2 Positive

Explore clinical trials studying CLDN18.2 Positive. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

CLDN18.2 Positive trial results

Recruiting

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

NCT07483554

Conditions: CLDN18.2 Positive, Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
Locations: The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

NCT07483567

Conditions: CLDN18.2 Positive, Gastroesophageal Junction Adenocarcinoma, Primary Gastric Adenocarcinoma
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details